Vanguard Personalized Indexing Management
SUPN icon

Vanguard Personalized Indexing Management’s Supernus Pharmaceuticals SUPN Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$370K Sell
7,963
-1,121
-12% -$53.8K ﹤0.01% 1577
2026
Q1 		$470K Buy
9,084
+2,484
+38% +$126K ﹤0.01% 1350
2025
Q4 		$328K Buy
6,600
+34
+0.5% +$1.65K ﹤0.01% 1468
2025
Q3 		$314K Buy
6,566
+75
+1% +$3.02K ﹤0.01% 1482
2025
Q2 		$205K Buy
+6,491
New +$208K ﹤0.01% 1622

Other funds holding SUPN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return

Vanguard Personalized Indexing Management's SUPN Position: Q2 2026 in Review

Vanguard Personalized Indexing Management reduced its Supernus Pharmaceuticals (SUPN) stake by 12% in Q2 2026, selling an estimated $53.8K and leaving 7,963 shares worth $370K. The position accounts for ﹤0.01% of the portfolio, ranked #1577.

Vanguard Personalized Indexing Management first reported a position in SUPN in Q2 2025 and has held it in 5 quarters since. The position peaked at $470K in Q1 2026. 334 funds tracked by Wall St. Rank hold SUPN as of Q2 2026.

  • Vanguard Personalized Indexing Management held 7,963 shares of Supernus Pharmaceuticals worth $370K as of Q2 2026.
  • Vanguard Personalized Indexing Management sold 1,121 Supernus Pharmaceuticals shares in Q2 2026, an estimated $53.8K.
  • Supernus Pharmaceuticals made up ﹤0.01% of Vanguard Personalized Indexing Management's portfolio in Q2 2026, its #1577 holding.
  • Vanguard Personalized Indexing Management first reported a position in Supernus Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
  • Vanguard Personalized Indexing Management's Supernus Pharmaceuticals position peaked at $470K in Q1 2026.
  • 334 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q2 2026.

Based on Vanguard Personalized Indexing Management's 13F filing for Q2 2026, filed 11 Aug 2026.